LUNG Pulmonx Corp

CIK 0001127537 14 ready 8-Ks latest April 29, 2026, 7:59 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 14

Latest filing April 29, 2026, 7:59 PM ET

Top materiality 0.85

Event mix earnings ×9 · other_material ×2 · debt ×1

Sentiment 4 pos · 3 neg · 7 neu

Latest earnings reported 2026-Q1

Recent 8-K filings for LUNG

Highest-materiality recent filing

Pulmonx reappoints Glen French as CEO and Derrick Sung as COO/CFO; Q3 preliminary revenue ~$21.5M

October 27, 2025, 7:59 PM ET leadership materiality 0.85 negative item 2.02 item 5.02 item 9.01

Glen French (former CEO 2014-2024) reappointed President and CEO; Derrick Sung (former CFO) appointed COO and CFO effective Nov 3, 2025.
Steve Williamson and Mehul Joshi resigned as CEO and CFO; each will serve as advisors through Dec 1, 2025; departures not due to any disagreement.

Read filing →

April 29, 2026, 7:59 PM ET earnings materiality 0.60 negative item 2.02 item 9.01 ◈ Earnings Releases

Pulmonx Q1 revenue falls 9% YoY to $20.6M; net loss $13.7M

Worldwide revenue $20.6M (-9% YoY, -12% constant currency); U.S. $13.3M (-7%), international $7.3M (-12%).
March 5, 2026, 6:59 PM ET debt materiality 0.70 neutral item 1.01 item 1.02 item 2.03 item 3.02 item 9.01 ◈ Debt Financings◈ Material Agreements

Pulmonx enters $60M secured credit facility with Perceptive; draws $40M upfront

$60M senior secured term loan from Perceptive; $40M drawn at closing, up to $20M additional tranches tied to $92.5M and $100M revenue milestones.
March 4, 2026, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

Pulmonx Q4 revenue declines 5% YoY; full year up 8%; guides flat FY2026 revenue $90-92M

Q4 2025 revenue $22.6M, down 5% YoY (down 7% constant currency); US revenue fell 11% to $14.1M.
November 12, 2025, 6:59 PM ET earnings materiality 0.65 neutral item 2.02 item 9.01

Pulmonx Q3 rev $21.5M (+5%), net loss $14.0M; guides FY rev $89-90M; adds COO role

Worldwide revenue $21.5M (+5% YoY); US $14.0M (+1%), Intl $7.5M (+15%).
October 27, 2025, 7:59 PM ET leadership materiality 0.85 negative item 2.02 item 5.02 item 9.01

Pulmonx reappoints Glen French as CEO and Derrick Sung as COO/CFO; Q3 preliminary revenue ~$21.5M

Glen French (former CEO 2014-2024) reappointed President and CEO; Derrick Sung (former CFO) appointed COO and CFO effective Nov 3, 2025.
July 30, 2025, 7:59 PM ET earnings materiality 0.78 negative item 2.02 item 9.01

Pulmonx Q2 revenue up 15% to $23.9M but cuts FY2025 guidance to $90-92M

Revenue $23.9M (+15% YoY); U.S. $14.7M (+6%), International $9.1M (+32% constant currency +27%).
April 30, 2025, 7:59 PM ET earnings materiality 0.80 positive item 2.02 item 9.01

Pulmonx Q1 2025 revenue $22.5M (+20% YoY); net loss $14.4M; reaffirms FY guidance

Worldwide revenue of $22.5M, up 20% YoY (21% constant currency); U.S. $14.2M (+11%), international $8.3M (+39%).
February 19, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02 item 9.01

Pulmonx reports record Q4 revenue $23.8M (+23% YoY) and FY2024 revenue $83.8M (+22%); FY2025 guidance $96-98M

Record Q4 2024 worldwide revenue $23.8M, up 23% YoY; U.S. revenue $15.9M (+16%), international $7.9M (+42%).
July 31, 2024, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

Pulmonx reports record Q2 revenue $20.8M (+21% YoY); net loss narrows to $15.3M

Worldwide revenue $20.8M, up 21% YoY; U.S. revenue $13.9M (+26%); International $6.9M (+12%).
May 1, 2024, 7:59 PM ET earnings materiality 0.70 positive item 2.02 item 9.01

Pulmonx Q1 revenue $18.9M (+30% YoY); net loss narrows to $13.7M

Q1 revenue $18.9M, up 30% YoY (29% constant currency); U.S. revenue $12.9M (+38%).

Earnings & guidance

2026-Q1 EPS reported -$0.33 filing →

Materiality & sentiment trend

Max materiality 0.85 · Median 0.68 · Most common event earnings

4 positive 3 negative 7 neutral

source · LUNG on sec.gov